TSPO and Alzheimer disease: More interestingly, it has recently been demonstrated that TSPO ligands, such as XBD173, ameliorate AD pathology through TSPO-dependent modulation of neurosteroids 12-17, and these ligands seem to play a major role in ameliorating the energy burden occurring in AD.